IN2004CH00875A - - Google Patents

Info

Publication number
IN2004CH00875A
IN2004CH00875A IN875CH2004A IN2004CH00875A IN 2004CH00875 A IN2004CH00875 A IN 2004CH00875A IN 875CH2004 A IN875CH2004 A IN 875CH2004A IN 2004CH00875 A IN2004CH00875 A IN 2004CH00875A
Authority
IN
India
Application number
Inventor
Hans-Ulrich Petereit
Christian Meier
Erna Roth
Andreas Gryczke
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of IN2004CH00875A publication Critical patent/IN2004CH00875A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN875CH2004 2002-08-27 2004-04-26 IN2004CH00875A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10239999A DE10239999A1 (en) 2002-08-27 2002-08-27 Granules or powders for the preparation of coating and binding agents for dosage forms

Publications (1)

Publication Number Publication Date
IN2004CH00875A true IN2004CH00875A (en) 2006-01-13

Family

ID=31197526

Family Applications (1)

Application Number Title Priority Date Filing Date
IN875CH2004 IN2004CH00875A (en) 2002-08-27 2004-04-26

Country Status (16)

Country Link
US (1) US7175857B2 (en)
EP (1) EP1432409B1 (en)
JP (1) JP4571861B2 (en)
KR (1) KR100942667B1 (en)
AT (1) ATE408401T1 (en)
AU (1) AU2003266232A1 (en)
BR (1) BRPI0306143B8 (en)
CA (1) CA2464502C (en)
DE (2) DE10239999A1 (en)
ES (1) ES2314275T3 (en)
IL (2) IL161145A0 (en)
IN (1) IN2004CH00875A (en)
MX (1) MX250472B (en)
PL (1) PL206233B1 (en)
SI (1) SI1432409T1 (en)
WO (1) WO2004019918A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10208344A1 (en) 2002-02-27 2003-09-04 Roehm Gmbh Melt extrusion of active ingredient salts
DE10260921A1 (en) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Process for coating substrates for pharmaceutical applications with a mixture of two film-forming coating agents
DE10260920A1 (en) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Process for the preparation of pharmaceutical forms or food supplements with pigmented polymer coatings
DE10260919A1 (en) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Process for the preparation of coated dosage forms and dietary supplements with concentration gradients in the coating
DE10304403A1 (en) 2003-01-28 2004-08-05 Röhm GmbH & Co. KG Process for the preparation of an oral dosage form with immediate disintegration and drug release
DE102004029573A1 (en) * 2004-06-18 2005-12-29 Gambro Lundia Ab Apheresis material or adsorbant for removing, depleting or inactivating macrophage migration inhibitory factor, comprises macrophage migration inhibitory factor-binding molecules on a solid carrier
WO2006046560A1 (en) * 2004-10-29 2006-05-04 Taiho Pharmaceutical Co., Ltd. Propiverine-containing oral particulate preparation and process for producing the same
EP1681049A1 (en) * 2005-01-12 2006-07-19 Physica Pharma Pharmaceutical composition and dosage form fast-disintegrating in the mouth , and process to prepare it
EP1879583A2 (en) * 2005-05-03 2008-01-23 Mutual Pharmaceutical Company, Inc. Quinine formulations
DE102005042039A1 (en) * 2005-09-02 2007-03-08 Basf Ag Aqueous polyvinyl acetate dispersions with high shear stability
ATE462416T1 (en) * 2006-08-04 2010-04-15 Ethypharm Sa MULTI-LAYER OROUGH DISSOLVING TABLET
WO2009016258A1 (en) 2007-08-02 2009-02-05 Basf Se Aqueous polymer dispersion based on n,n-diethylaminoethyl methacrylate, its preparation and use
US20100062062A1 (en) * 2008-09-11 2010-03-11 Aethos Pharmaceuticals, Inc. Stabilized Coating for Pharmaceutical Formulations
JP5693594B2 (en) 2009-10-28 2015-04-01 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Stable protective coating for pharmaceutical dosage forms
US20110150986A1 (en) * 2009-12-18 2011-06-23 Kristin Arnold Quinine formulations, method of making, and metho of use thereof
BR112012022775A2 (en) * 2010-03-10 2016-07-19 Nogra Pharma Ltd colon cleansing compositions and methods for producing and using them
CA2799110A1 (en) 2010-05-10 2011-11-17 Evonik Roehm Gmbh Pharmaceutical dosage form comprising one or more antiretroviral active ingredients
WO2012031934A1 (en) 2010-09-07 2012-03-15 Basf Se Use of copolymers based on polymers containing amino groups as a matrix binder for the production of active ingredient-containing granules and administration forms
US9795576B2 (en) * 2010-09-27 2017-10-24 Basf Se Protective coatings for acidic active ingredients
JP6012604B2 (en) 2010-09-27 2016-10-25 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Protective coating for acidic active ingredients
US8865250B2 (en) 2011-02-28 2014-10-21 Basf Se Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
JP5937113B2 (en) 2011-02-28 2016-06-22 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Production of powder coatings for stable protective coatings for pharmaceutical dosage forms
US8962064B2 (en) 2011-02-28 2015-02-24 Basf Se Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
JP6027550B2 (en) 2011-02-28 2016-11-16 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Production of powder coatings for stable protective coatings for pharmaceutical dosage forms
US9044734B2 (en) 2011-09-23 2015-06-02 Basf Se Diesel oxidation catalyst with layered structure containing ceria composition as palladium support material for enhanced HC and CO gas conversion
EP2636403A1 (en) * 2012-03-09 2013-09-11 Basf Se Production of pharmaceutical protective overalls with good resistance in a neutral environment
US20130236505A1 (en) 2012-03-09 2013-09-12 Basf Se Production Of Pharmaceutical Protective Coatings With Good Resistance In A Neutral Environment
US10668156B2 (en) 2012-06-22 2020-06-02 Basf Se Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers
WO2013189776A1 (en) 2012-06-22 2013-12-27 Basf Se Active ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers
US20150290136A1 (en) * 2012-11-22 2015-10-15 Evonik Roehm Gmbh Process for preparing a granulated product from a powder composition
FR3027802B1 (en) * 2014-10-31 2018-03-02 Ethypharm DOUBLE MASKING TASTE ACTIVE PRINCIPLE GRANULES, PROCESS FOR THEIR PREPARATION AND ORODISPERSIBLE TABLETS CONTAINING SAME
GR1008992B (en) * 2015-12-17 2017-03-23 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων Oral pharmaceutical composition in the form of granules comprising metronidazole or derivatives thereofand a taste-masking agent
EP3569225A1 (en) * 2018-05-18 2019-11-20 Pharmaceutical Oriented Services Ltd Solid dispersion containing ritonavir
WO2020138407A1 (en) * 2018-12-27 2020-07-02 興和株式会社 Medicinal product

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0164669B1 (en) * 1984-06-13 1991-01-23 Röhm Gmbh Process for coating pharmaceutical forms
DE3920082A1 (en) * 1989-06-20 1991-03-07 Roehm Gmbh FILM-FORMING AQUEOUS COATING AGENT FOR SOLID MEDICINAL PRODUCTS, METHOD FOR THE PRODUCTION AND USE THEREOF
DE29502547U1 (en) * 1995-02-16 1995-03-30 Roehm Gmbh Thermoplastic coating and binding agent for pharmaceutical forms
DE19918435A1 (en) * 1998-07-23 2000-01-27 Roehm Gmbh Coating or binding agent for medicaments, prepared using finely divided acrylic copolymer powder, used e.g. for taste-masking coatings or in transdermal delivery systems
DE19958007A1 (en) * 1999-12-02 2001-06-07 Roehm Gmbh Injection molding process for (meth) acrylate copolymers with tertiary ammonium groups
DK1311820T3 (en) * 2000-07-14 2015-04-07 Janssen Diagnostics Llc Increased separation efficiency via a controlled aggregation of magnetic nanoparticles
KR100510356B1 (en) * 2001-02-27 2005-08-24 룀 게엠베하 운트 콤파니 카게 Pharmaceutical formulations comprising a coating and binding agent with improved storage stability and process for the preparation thereof
DE10208344A1 (en) * 2002-02-27 2003-09-04 Roehm Gmbh Melt extrusion of active ingredient salts

Also Published As

Publication number Publication date
EP1432409A1 (en) 2004-06-30
CA2464502C (en) 2010-11-23
US7175857B2 (en) 2007-02-13
BR0306143A (en) 2004-10-19
BRPI0306143B8 (en) 2021-05-25
DE10239999A1 (en) 2004-03-04
IL161145A (en) 2010-11-30
BRPI0306143B1 (en) 2016-03-08
US20050197434A9 (en) 2005-09-08
PL206233B1 (en) 2010-07-30
MX250472B (en) 2007-10-17
SI1432409T1 (en) 2009-02-28
WO2004019918A1 (en) 2004-03-11
JP2005536555A (en) 2005-12-02
KR100942667B1 (en) 2010-02-17
MXPA04003970A (en) 2004-06-22
IL161145A0 (en) 2004-08-31
JP4571861B2 (en) 2010-10-27
ES2314275T3 (en) 2009-03-16
DE50310506D1 (en) 2008-10-30
KR20050034620A (en) 2005-04-14
ATE408401T1 (en) 2008-10-15
CA2464502A1 (en) 2004-03-11
PL368186A1 (en) 2005-03-21
EP1432409B1 (en) 2008-09-17
AU2003266232A1 (en) 2004-03-19
US20040249035A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
BE2019C547I2 (en)
BE2019C510I2 (en)
BE2018C021I2 (en)
BE2017C049I2 (en)
BE2017C005I2 (en)
BE2016C069I2 (en)
BE2016C040I2 (en)
BE2018C018I2 (en)
BE2014C053I2 (en)
BE2014C051I2 (en)
BE2014C041I2 (en)
BE2014C030I2 (en)
BE2014C016I2 (en)
BE2014C015I2 (en)
BE2013C063I2 (en)
BE2013C039I2 (en)
BE2011C038I2 (en)
JP2003163282A5 (en)
IN2004CH00875A (en)
JP2003162975A5 (en)
BRPI0302144B1 (en)
BRPI0215435A2 (en)
BE2013C046I2 (en)
JP2003245446A5 (en)
JP2003210060A5 (en)